Here, we showed that in three NSCLC cell lines, glucosamine could also downregulate CDK4 and CDK2 expression and that the extent of the glucosamine-mediated inhibition of these proteins reflected the proportion of cells arrested in the G0/G1 phase (Figure 1B and D). The gene discussed is CDK4; the disease is non-small cell lung carcinoma.